Implementation of Molecular Diagnostics for SARS-CoV-2

This session introduces the keypoints in validating RT-PCR testing of SARS-CoV-2, and presents findings at a provincial center of CoVID-19 on positive rate of molecular testing from multiple specimen sources.

This presentation is provided in collaboration with: 

N  A  C  C  C  A

North American Chinese Clinical Chemists Association

The North American Chinese Clinical Chemistry Association (NACCCA) is a non-profit organization that currently serves hundreds of clinical chemists, scientists, physicians, and physicians from many different countries.

This presentation was organized by NACCCA and includes both this presentation and another scientific presentation, as well as a panel discussion. Laboratory methods, positive rate on various specimens, and method validation process will be introduced. The panel forum will focus on specimen collection process and safety for laboratory professionals.